five

Androgen receptor-coregulators hormone responsiveness LNCaP / GSF

收藏
NIAID Data Ecosystem2026-03-07 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE4454
下载链接
链接失效反馈
官方服务:
资源简介:
The text description is: LNCaP are androgen receptor expressing prostate carcinoma cells. Genital skin fibroblasts also express the androgen receptor. Cells were either proliferating or they were G0-arrested. Treatment of cells was performed with either the androgen DHT (dihydrotestosterone), the androgen analogue R1881 (methyltrienolone), or the solvent ethanol. Some hybridizations were performed in the type 1 design. In these cases, the hormone treated sample was hybridized against the ethanol treated sample on the same microarray. Hormone mediated induction or repression of gene transcription can directly be deduced from R/G normalized ratios on arrays. For other experiments, the ethanol treated control and the hormone treated experiment were hybridized on separate microarrays against a common reference of RNA. This reference was composed out of common reference batch CRG (50%) and a fibroblast RNA (50%). This reference was called mixed reference. For all experiments, the same batch of mixed reference was used. A compound treatment design type is where the response to administration of a compound or chemical (including biological compounds such as hormones) is assayed. Compound Based Treatment: Ethanol, R1881 (methyltrienolone), or DHT (dihydrotestosterone) Cell Line: LNCaP (prostate cancer) or foreskin fibroblasts Culture Synchrony: proliferation / Go-arrest Keywords: compound_treatment_design Computed

本数据集涉及的细胞包括:表达雄激素受体(androgen receptor)的LNCaP前列腺癌细胞,以及同样表达雄激素受体的生殖器皮肤成纤维细胞。所培养的细胞分为两种状态:增殖状态与G0期阻滞(G0-arrested)状态。细胞分别经雄激素双氢睾酮(dihydrotestosterone, DHT)、雄激素类似物甲基曲诺酮(methyltrienolone, R1881)或溶剂乙醇处理。部分杂交实验采用1型设计:将激素处理样品与乙醇处理样品在同一张微阵列(microarray)上进行杂交,此时可通过芯片的R/G归一化比值直接推导激素介导的基因转录上调或下调情况。其余实验中,乙醇处理的对照组与激素处理的实验组分别与通用参考RNA在独立的微阵列上完成杂交。该通用参考样本由50%的CRG通用参考批次与50%的成纤维细胞RNA混合制备,被称为混合参考样本(mixed reference),所有实验均使用同一批次的该混合参考样本。化合物处理实验设计指对化合物或化学物质(包括激素这类生物活性化合物)给药后的细胞应答进行检测的实验类型。本数据集的化合物处理方案包含乙醇、R1881(甲基曲诺酮)及DHT(双氢睾酮);所用细胞系为LNCaP(前列腺癌)细胞或包皮成纤维细胞;培养同步状态为增殖/G0期阻滞。关键词:化合物处理实验设计(compound_treatment_design),经计算
创建时间:
2012-03-17
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作